Back to Search Start Over

Post-GWAS functional analysis identifies CUX1 as a regulator of p16 INK4a and cellular senescence.

Authors :
Jiang D
Sun W
Wu T
Zou M
Vasamsetti SB
Zhang X
Zhao Y
Phillippi JA
Sawalha AH
Tavakoli S
Dutta P
Florentin J
Chan SY
Tollison TS
Di Wu
Cui J
Huntress I
Peng X
Finkel T
Li G
Source :
Nature aging [Nat Aging] 2022 Feb; Vol. 2 (2), pp. 140-154. Date of Electronic Publication: 2022 Feb 17.
Publication Year :
2022

Abstract

Accumulation of senescent cells with age is an important driver of aging and age-related diseases. However, the mechanisms and signaling pathways that regulate senescence remain elusive. In this report, we performed post-genome-wide association studies (GWAS) functional studies on the CDKN2A/B locus, a locus known to be associated with multiple age-related diseases and overall human lifespan. We demonstrate that transcription factor CUX1 (Cut-Like Homeobox 1) specifically binds to an atherosclerosis-associated functional single-nucleotide polymorphism (fSNP) (rs1537371) within the locus and regulates the CDKN2A/B-encoded proteins p14 <superscript>ARF</superscript> , p15 <superscript>INK4b</superscript> and p16 <superscript>INK4a</superscript> and the antisense noncoding RNA in the CDK4 (INK4) locus (ANRIL) in endothelial cells (ECs). Endothelial CUX1 expression correlates with telomeric length and is induced by both DNA-damaging agents and oxidative stress. Moreover, induction of CUX1 expression triggers both replicative and stress-induced senescence via activation of p16 <superscript>INK4a</superscript> expression. Thus, our studies identify CUX1 as a regulator of p16 <superscript>INK4a</superscript> -dependent endothelial senescence and a potential therapeutic target for atherosclerosis and other age-related diseases.<br /> (© 2022. The Author(s).)

Details

Language :
English
ISSN :
2662-8465
Volume :
2
Issue :
2
Database :
MEDLINE
Journal :
Nature aging
Publication Type :
Academic Journal
Accession number :
37117763
Full Text :
https://doi.org/10.1038/s43587-022-00177-0